Condition
Cheyne Stokes Respiration
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03092388Not ApplicableCompleted
Leg Fluid Shift in Patients With Chronic Heart Failure and Obstructive or Central Sleep Apnea
NCT01124370Phase 2Completed
Chronic Evaluation of Respicardia Therapy
NCT00563693Not ApplicableCompleted
Chronic Heart Failure - Cheyne Stokes Respiration - CS2 (3C-study)
NCT01164592Phase 4Completed
Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
NCT01095679Phase 1CompletedPrimary
Baclofen and Hypoxia-induced Periodic Ventilation
Showing all 5 trials